Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05801965 | A Digital Therapeutic Solution for Cancer Patients | completed | N/A | 48 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT05065944 | Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center | completed | — | 106 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT04890314 | Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment(PC-CONCEPT) | completed | — | 1,953 | Weill Medical College of Cornell UniversityOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06984159 | The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. | completed | Phase 3 | 137 | Changchun GeneScience Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 22, 2025 | clinicaltrials |
| NCT06389695 | Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients | completed | Phase 1 / Phase 2 | 20 | Norroy Bioscience Co., LTDINDUSTRY | 1 | May 21, 2025 | clinicaltrials |
| NCT00328614 | Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer | completed | Phase 1 | 32 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04390880 | 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer(PROSPYL) | completed | Phase 2 | 239 | VA Greater Los Angeles Healthcare SystemFED | 1 | May 16, 2025 | clinicaltrials |
| NCT01420250 | Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer | completed | Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT02788773 | Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer | completed | Phase 2 | 52 | Canadian Cancer Trials GroupNETWORK | 1 | May 15, 2025 | clinicaltrials |
| NCT03807492 | Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) | completed | — | 241 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT03987217 | Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients | completed | Early Phase 1 | 73 | University of UtahOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05671094 | Implementation of a Multimodal Prehabilitation Program in Robotic Oncological Surgery | completed | N/A | 21 | Jessa HospitalOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05903781 | Value of Ultra-fast Prostate MRI in Prostate Cancer | completed | — | 536 | University of ZurichOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT02278185 | Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer | completed | Phase 2 | 19 | University of Colorado, DenverOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT04332744 | Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)(ZZ-First) | completed | Phase 2 | 54 | MedSIROTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT03570619 | Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations(IMPACT) | completed | Phase 2 | 56 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT04113811 | Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer | completed | N/A | 30 | Chinese University of Hong KongOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT04685928 | Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy(SMART) | completed | N/A | 403 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06500741 | Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients | completed | — | 374 | Astellas Pharma Global Development, Inc.INDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT01162135 | Digoxin for Recurrent Prostate Cancer | completed | Phase 2 | 16 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT01848067 | Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 9 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT02603965 | Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery | completed | Phase 1 | 25 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT03013413 | Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy | completed | N/A | 99 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02339168 | Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer | completed | Phase 1 | 25 | University of California, DavisOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06950996 | A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum | completed | — | 300 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT02983279 | Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer | completed | N/A | 49 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT03076203 | Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) | completed | Phase 1 | 14 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT02989623 | Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA | completed | N/A | 25 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT00026754 | Eligibility Screening for the NIH Intramural Research Program Clinical Protocols | completed | — | 19,522 | National Cancer Institute (NCI)NIH | 1 | Apr 18, 2025 | clinicaltrials |
| NCT06237114 | Novel Robotic Prostatectomy Technique for Early Urinary Continence(TRS-RALP) | completed | — | 30 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT03936218 | Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer | completed | Phase 3 | 94 | Eurofarma Laboratorios S.A.INDUSTRY | 1 | Apr 17, 2025 | clinicaltrials |
| NCT02025010 | Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer | completed | Phase 2 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06929065 | Randomized Trial of HIFU vs. Cryo for Prostate Cancer(KPFT) | completed | N/A | 50 | Kaiser PermanenteOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT01220869 | A Study of Degarelix in Taiwanese Patients With Prostate Cancer | completed | Phase 3 | 110 | Ferring PharmaceuticalsINDUSTRY | 1 | Apr 13, 2025 | clinicaltrials |
| NCT03261271 | Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy(WARRIOR) | completed | N/A | 40 | University of Kansas Medical CenterOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT02435472 | Active Surveillance Exercise Clinical Trial(ASX) | completed | N/A | 104 | University of California, San FranciscoOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT03661437 | Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy | completed | Early Phase 1 | 33 | City of Hope Medical CenterOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT06919159 | Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer | completed | — | 45 | Jiequn YuOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT03934606 | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | completed | — | 1,488 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT05317143 | Evaluation of Prostate Cancer Margins | completed | — | 100 | Intuitive SurgicalINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT02288247 | A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone(PRESIDE) | completed | Phase 3 | 688 | Astellas Pharma Europe Ltd.INDUSTRY | 16 | Apr 8, 2025 | clinicaltrials |
| NCT06482658 | Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer | completed | N/A | 380 | Peking University First HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT03768349 | PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer | completed | Early Phase 1 | 250 | Mayo ClinicOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT03654638 | Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer | completed | Phase 2 | 25 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | completed | Phase 1 | 269 | ExelixisINDUSTRY | 9 | Apr 4, 2025 | clinicaltrials |
| NCT03668652 | Focal Prostate Ablation Versus Radical Prostatectomy(FARP) | completed | N/A | 213 | Oslo University HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06377683 | Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 8 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT04600336 | Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer | completed | Phase 2 | 88 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT03093428 | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | completed | Phase 2 | 45 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT03087903 | A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA | completed | N/A | 41 | University of Colorado, DenverOTHER | 1 | Mar 25, 2025 | clinicaltrials |
Data updated 23 days agoSource updated May 25, 2025source: clinicaltrials